Organisation mondiale de la santé (OMS) · Press Releases, Fact Sheets, Newsletters, Statements

MERS situation update: May 2021

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

The aim of this situation update is to provide the epidemiological status of MERS in the Region in order to aid better planning, coordination and response. The information in this document has been reported to WHO by Ministries of Health. For further information, contact: Tel + 20-2-22765492, Fax + 20-2-2765456 E-mail: emrgohspoutbreak@who Published by World Health Organization Regional Office for the Eastern Mediterranean Monazamet El Seha El Alamia Str,Extension of Abdel Razak El Sanhouri Street P.O. Box 7608, Nasr City Cairo 11371, Egypt www.emro.who.int © World Health Organization 2021 Highlights MERS SITUATION UPDATE | MAY 2021 Distribution of MERS reported cases from Eastern Mediterranean Region by week of onset, June 2012 – May 2021 Tunisia United Arab Emirates Bahrain Egypt Iran (Islamic republic of) Jordan Kuwait Lebanon Oman Qatar Yemen Saudi Arabia 0 20 40 60 80 100 120 140 N um be r of c as es At the end of May 2021, a total of 2574 laboratory-confirmed cases of Middle East respiratory syndrome (MERS), including 886 associated deaths (case–fatality rate: 34.4%) were reported globally; the majority of these cases were reported from Saudi Arabia (2174 cases, including 808 related deaths with a case–fatality rate of 37.2%). During the month of May 2021, no laboratory-confirmed case of MERS were reported to WHO. The demographic and epidemiological characteristics of reported cases, when compared during the same corresponding period of 2015 to 2020, do not show any significant difference or change. The age group 50–59 years continues to be at the highest risk for acquiring infection of primary cases. The age group 30–39 years is most at risk for secondary cases. The number of deaths is higher in the age group 50–59 years for primary cases and 70–79 years for secondary cases. . . . . SUMMARY 2574 Laboratory-confirmed cases reported since April 2012 886 Deaths reported since April 2012 27 Countries reported cases globally 12 Countries reported cases since April 2012 in the Eastern Mediterranean Region Epidemiological characteristics of MERS cases reported globally between November 2015 - April 2016 and November 2020 - May 2021 Characteristic Number Median age in years Gender (% male) % of Primary Cases % of Secondary cases (%) of Unknown Contact History % of HCW % Fatal Dec 15 - May 16 108 56 82 50 45 5 89 34 Dec 16 - May 17 123 55 78 57 34 9 90 30 Dec 17 - May 18 104 54 79 56 44 0 95 33 Dec 18 - May 19 168 51 76 34 66 0 81 23 Dec 19 - May 20 65 58 82 23 16 61 94 35 Dec 20 - May 21 9 58 89 71 0 29 89 44 Characteristics of MERS cases reported from Saudi Arabia, June 2012 - May 2021 Type of case Missing Primary Secondary Unknown Grand Total 2012 3 2 5 2013 1 36 93 28 158 2014 15 164 264 219 662 2015 102 52 222 78 454 2016 103 75 60 11 249 2017 68 70 90 5 233 2018 52 54 35 1 142 2019 56 57 75 16 204 2020 7 11 9 33 60 2021 2 3 2 7 Grand Total 406 525 850 393 2174 MERS cases per week of onset in Saudi Arabia, June 2012 – May 2021 Survived Died Age and fatality distribution of primary and secondary cases of MERS reported from Saudi Arabia June 2012 – May 2021 30 25 20 15 10 5 0 5 10 15 20 25 00-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90&> 90 % A ge G ro u p Survived Died Primary Secondary Cases of MERS in healthcare workers reported from Saudi Arabia, January 2013 – May 2021 0 50 100 150 200 250 N u m b er o f ca se s Month Non-HCW HCW Community versus hospital acquired MERS cases in Eastern Mediterranean Region, January 2014 – April 2021 Community acquired Hospital acquired 0 10 20 30 40 50 60 70 80 90 100 N um be r of M ER S ca se s Epi week 0 50 100 150 200 250 300 2014 2015 2016 2017 2018 2019 2020 2021 N u m b er o f ca se s Year 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 5 7 9 11 1 3 2013 2014 2015 2016 2017 2018 2019 2020 2021 111621263136414651 4 9 1419242934394449 2 7 121722273237424752 4 9 1419242934394449 2 7 121722273237424752 5 101520253035404550 3 8 1318232833384348 2 7 121722273237424752 5 101520253035404550 3 8 1318 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Epi week 26303438424650 2 6 1014182226303438424650 1 5 9 1317212529333741454953 4 8 1216202428323640444852 4 8 1216202428323640444852 4 8 1216202428323640444852 4 8 1216202428323640444852 4 8 12162024283236404448 1 5 9 13172125293337414549 1 5 9 1317 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Document number: WHO-EM/CSR/417/E

Informations clés
Date d'adoption
Source Organisation mondiale de la santé